Boe J - Search Results

1

Single lung transplantation as treatment for end-stage pulmonary sarcoidosis: recurrence of sarcoidosis in two different lung allografts in one patient.

Bjørtuft O, Foerster A, Boe J, Geiran O. Bjørtuft O, et al. Among authors: boe j. J Heart Lung Transplant. 1994 Jan-Feb;13(1 Pt 1):24-9. J Heart Lung Transplant. 1994. PMID: 8167124

2

The energy intake that is needed for weight gain in COPD candidates for lung transplantation.

Førlil L, Boe J. Førlil L, et al. Among authors: boe j. COPD. 2005 Dec;2(4):405-10. doi: 10.1080/15412550500346451. COPD. 2005. PMID: 17147005

3

Lung transplantation in patients with chronic obstructive pulmonary disease in a national cohort is without obvious survival benefit.

Stavem K, Bjørtuft Ø, Borgan Ø, Geiran O, Boe J. Stavem K, et al. Among authors: boe j. J Heart Lung Transplant. 2006 Jan;25(1):75-84. doi: 10.1016/j.healun.2005.06.025. Epub 2005 Dec 9. J Heart Lung Transplant. 2006. PMID: 16399534

4

Vitamins A and E in serum in relation to weight and lung function in patients with advanced pulmonary disease.

Førli L, Pedersen JI, Bjørtuft O, Blomhoff R, Kofstad J, Boe J. Førli L, et al. Among authors: boe j. Int J Vitam Nutr Res. 2002 Dec;72(6):360-8. doi: 10.1024/0300-9831.72.6.360. Int J Vitam Nutr Res. 2002. PMID: 12596500

5

The influence of underweight and dietary support on well-being in lung transplant candidates.

Førli L, Moum T, Bjørtuft O, Vatn M, Boe J. Førli L, et al. Among authors: boe j. Respir Med. 2006 Jul;100(7):1239-46. doi: 10.1016/j.rmed.2005.10.016. Epub 2005 Nov 28. Respir Med. 2006. PMID: 16311026 Free article. Clinical Trial.

6

Vitamin D deficiency, bone mineral density and weight in patients with advanced pulmonary disease.

Førli L, Halse J, Haug E, Bjørtuft Ø, Vatn M, Kofstad J, Boe J. Førli L, et al. Among authors: boe j. J Intern Med. 2004 Jul;256(1):56-62. doi: 10.1111/j.1365-2796.2004.01337.x. J Intern Med. 2004. PMID: 15189366 Free article.

7

Health status, dyspnea, lung function and exercise capacity in patients with chronic obstructive pulmonary disease.

Stavem K, Boe J, Erikssen J. Stavem K, et al. Among authors: boe j. Int J Tuberc Lung Dis. 1999 Oct;3(10):920-6. Int J Tuberc Lung Dis. 1999. PMID: 10524591

8

Deaths from pulmonary tuberculosis in a low-incidence country.

Naalsund A, Heldal E, Johansen B, Kongerud J, Boe J. Naalsund A, et al. Among authors: boe j. J Intern Med. 1994 Aug;236(2):137-42. doi: 10.1111/j.1365-2796.1994.tb01275.x. J Intern Med. 1994. PMID: 8046312

9

Why do our patients die of active tuberculosis in the era of effective therapy?

Zafran N, Heldal E, Pavlovic S, Vuckovic D, Boe J. Zafran N, et al. Among authors: boe j. Tuber Lung Dis. 1994 Oct;75(5):329-33. doi: 10.1016/0962-8479(94)90077-9. Tuber Lung Dis. 1994. PMID: 7841425

10

Deaths from active tuberculosis: can we rely on notification and mortality figures?

Heldal E, Naalsund A, Kongerud J, Tverdal A, Boe J. Heldal E, et al. Among authors: boe j. Tuber Lung Dis. 1996 Jun;77(3):215-9. doi: 10.1016/s0962-8479(96)90003-9. Tuber Lung Dis. 1996. PMID: 8758103

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results